Cargando…

End-of-Life Care Decision-Making in Stroke

Stroke is one of the leading causes of death and long-term disability in the United States. Though advances in interventions have improved patient survival after stroke, prognostication of long-term functional outcomes remains challenging, thereby complicating discussions of treatment goals. Stroke...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Lucy, Zhao, Charlie W., Hwang, David Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505717/
https://www.ncbi.nlm.nih.gov/pubmed/34650502
http://dx.doi.org/10.3389/fneur.2021.702833
_version_ 1784581593373868032
author Gao, Lucy
Zhao, Charlie W.
Hwang, David Y.
author_facet Gao, Lucy
Zhao, Charlie W.
Hwang, David Y.
author_sort Gao, Lucy
collection PubMed
description Stroke is one of the leading causes of death and long-term disability in the United States. Though advances in interventions have improved patient survival after stroke, prognostication of long-term functional outcomes remains challenging, thereby complicating discussions of treatment goals. Stroke patients who require intensive care unit care often do not have the capacity themselves to participate in decision making processes, a fact that further complicates potential end-of-life care discussions after the immediate post-stroke period. Establishing clear, consistent communication with surrogates through shared decision-making represents best practice, as these surrogates face decisions regarding artificial nutrition, tracheostomy, code status changes, and withdrawal or withholding of life-sustaining therapies. Throughout decision-making, clinicians must be aware of a myriad of factors affecting both provider recommendations and surrogate concerns, such as cognitive biases. While decision aids have the potential to better frame these conversations within intensive care units, aids specific to goals-of-care decisions for stroke patients are currently lacking. This mini review highlights the difficulties in decision-making for critically ill ischemic stroke and intracerebral hemorrhage patients, beginning with limitations in current validated clinical scales and clinician subjectivity in prognostication. We outline processes for identifying patient preferences when possible and make recommendations for collaborating closely with surrogate decision-makers on end-of-life care decisions.
format Online
Article
Text
id pubmed-8505717
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85057172021-10-13 End-of-Life Care Decision-Making in Stroke Gao, Lucy Zhao, Charlie W. Hwang, David Y. Front Neurol Neurology Stroke is one of the leading causes of death and long-term disability in the United States. Though advances in interventions have improved patient survival after stroke, prognostication of long-term functional outcomes remains challenging, thereby complicating discussions of treatment goals. Stroke patients who require intensive care unit care often do not have the capacity themselves to participate in decision making processes, a fact that further complicates potential end-of-life care discussions after the immediate post-stroke period. Establishing clear, consistent communication with surrogates through shared decision-making represents best practice, as these surrogates face decisions regarding artificial nutrition, tracheostomy, code status changes, and withdrawal or withholding of life-sustaining therapies. Throughout decision-making, clinicians must be aware of a myriad of factors affecting both provider recommendations and surrogate concerns, such as cognitive biases. While decision aids have the potential to better frame these conversations within intensive care units, aids specific to goals-of-care decisions for stroke patients are currently lacking. This mini review highlights the difficulties in decision-making for critically ill ischemic stroke and intracerebral hemorrhage patients, beginning with limitations in current validated clinical scales and clinician subjectivity in prognostication. We outline processes for identifying patient preferences when possible and make recommendations for collaborating closely with surrogate decision-makers on end-of-life care decisions. Frontiers Media S.A. 2021-09-28 /pmc/articles/PMC8505717/ /pubmed/34650502 http://dx.doi.org/10.3389/fneur.2021.702833 Text en Copyright © 2021 Gao, Zhao and Hwang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Gao, Lucy
Zhao, Charlie W.
Hwang, David Y.
End-of-Life Care Decision-Making in Stroke
title End-of-Life Care Decision-Making in Stroke
title_full End-of-Life Care Decision-Making in Stroke
title_fullStr End-of-Life Care Decision-Making in Stroke
title_full_unstemmed End-of-Life Care Decision-Making in Stroke
title_short End-of-Life Care Decision-Making in Stroke
title_sort end-of-life care decision-making in stroke
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505717/
https://www.ncbi.nlm.nih.gov/pubmed/34650502
http://dx.doi.org/10.3389/fneur.2021.702833
work_keys_str_mv AT gaolucy endoflifecaredecisionmakinginstroke
AT zhaocharliew endoflifecaredecisionmakinginstroke
AT hwangdavidy endoflifecaredecisionmakinginstroke